Obstetric Ultrasound in Context of Coronavirus Pandemic
Background: Obstetric ultrasound has become in an essential exam in the prenatal care that could be affected by the changes resulting from currently coronavirus pandemic. Objective: To examine the available evidence regarding the recommendations about obstetric ultrasound scan to prevent deterioration in the quality of antenatal care in the context of SARS-CoV-2. Methods: Literature search of PubMed. Results and Conclusions: Enough works have demonstrated that the routine ultrasound scan helps to evaluate fetal growth and health, detect congenital anomalies, perform screening of maternal and fetal diseases, diagnose altered placental implantation and classify multiple gestation and its complications, improving maternal and perinatal outcomes. This pandemic is an exceptional situation where every relationship could be affected, but the prenatal care should not be deteriorated. As health practitioners, we have to provide safety and efficient in the evaluations of the obstetric patients.
Introduction
The obstetric ultrasound has evolved considerably over the past three decades from an examination only for obstetrical indications to a routine examination in every pregnancy. Because of the minimum risk and high efficiency that the echography has to mother and fetus, this health prenatal check has become in an essential exam that every pregnant woman, and their families, await with impatience. But nowadays, in context of SARS-CoV-2, the rationalization of the ultrasound use is needed for the patients and the physicians or sonographers. Coronavirus pandemic has altered our relationships and decreased all physical contact to reduce the infectious risk. This situation could result in an excessive drop in the prenatal ultrasound scans, which would lead to a deficient antenatal care.
Obstetric Ultrasound Development
Since the 1980s sonography has been used to monitor the pregnancy but lasted more than ten years to define its usefulness as routine screening exam during pregnancy [1]. The main change about the concept of obstetric ultrasound scan emerged from works as EUROCAT [2] and Eurofetus study [3], and other smaller works performed in each country [1, 4, 5]. Both European studies were be able to describe how the mayor malformations could be diagnosed prenatally, and how it influenced in the termination of the pregnancy [2, 3].
Previously, other studies had showed reasons to not use the ultrasound check as a routine exam [6, 7, 8, 9]. In this sense, RADIUS study described how the routine ultrasound did not improve perinatal outcome. They did not find differences between the group of patients who underwent two screening ultrasound scan and group where the ultrasonography only was made form medical indication about outcomes as preterm delivery, birth weight, detection of congenital anomalies and post-date complications [6]. However this study had multiple comments by scientifics from around the world [10, 11].
Posteriorly, enough works have demonstrated that the routine ultrasound scan helps to evaluate fetal growth and health, detect congenital anomalies, perform screening of maternal and fetal diseases, diagnose altered placental implantation and classify multiple gestation and its complications, improving perinatal outcomes [12].
Routine Prenatal Screening
To offer routine scan to all of pregnancies is essential because the most of congenital anomalies appears at the low- risk women [13]. It must be mentioned that detecting fetal structural malformations complicate around 2-3% of the pregnancies [2, 3]. The improvement of prenatal diagnosis allows to modify antenatal care and to prepare parents to the neonatal prognosis [14]. This permits to take decisions of pregnancy terminations in some cases [12, 15, 16, 17].
More benefits of ultrasound in obstetric is its safety both for the mother and her baby [18, 19]. This reason has permitted that obstetric ultrasound could be realized a lot of times during pregnancy. Every day, the obstetric ultrasound improves, therefore morphological anomalies and normal variants of the fetus are detected more accurate and earlier. This is due to the quick development of the ultrasound equipment and the high specialization of the ultrasound providers. However, there are some problems about the diagnosis by sonography that it is important to mention: overdiagnosis (false positive findings) and underdiagnosis (false negative findings) [12].
Several previous researches have studied the prenatal detection rate of fetal malformations. All available scientific studies agree that the prenatal care with the introduction of ultrasound screening decrease the maternal and perinatal adverse outcomes [1, 2, 3, 4, 5, 17]. It is described a detection rate during pregnancy by sonography from 44% to 83% for major anomalies, this variability depends on the anatomical system affected and the proficiency of the sonographer [1, 4, 20, 21, 22, 23]. Additionally, some anomalies are more detectable than other at antenatal life, most of works reported that the malformations of pulmonary and central nervous systems are the most antenatally detectable [2, 3, 4, 5, 16]. The false-positive rate was placed between 1 to 8%, being hydronephrosis and pleural effusions the most common [3, 4, 16, 22]. False positive is a problem because they are cause of family anxiety and use valued resources of perinatal care. The most important factor associated to false-positive rate on screening ultrasound scan is the maternal obesity [24].
Currently, the search for fetal structural anomalies at early gestational ages is performed at first trimester of pregnancy how the first opportunity to fetus and mother screening [14, 15, 25]. Third trimester scan allows to study evolutive malformations and to prepare birth and postnatal requirements [26].
It seen clear that obstetric ultrasound scan is required during pregnancy, but it has been also enough reported that the numbers of needed scans in a low-risk pregnancy is of three [25, 26]. The most of scientist studies report that the first trimester scan allows not only to date the pregnancy and to diagnose multiple gestation, but also to determinate fetal and maternal risks and some mayor fetal structural anomalies [27]; the second trimester is the principal scan to detect congenital anomalies; and third trimester scans are useful to diagnosis abnormal fetal growth [26, 28, 29].
Declaration of Interest
The authors report no conflicts of interest.
References
-
Saari Kemppainen A, Karjalainen O, Ylostalo P, Heinonen OP (1990) Ultrasound screening and perinatal mortality: controlled trial of systematic one-stage screening in pregnancy. The Helsinki Ultrasound Trial. Lancet 336(8712): 387-931.
-
Garne E, Loane M, Dolk H, De Vigan C, Scarano G, et al. (2005) Prenatal diagnosis of severe structural congenital malformations in Europe. Ultrasound Obstet Gynecol 25(1): 6-11.
-
Grandjean H, Larroque D, Levi S (1999) The performance of routine ultrasonographic screening of pregnancies in the Eurofetus Study. Am J Obstet Gynecol 181(2): 446- 54.
-
Boyd PA, Rounding C, Chamberlain P, Wellesley D, Kurinczuk JJ (2012) The evolution of prenatal screening and diagnosis and its impact on an unselected population over an 18-year period. BJOG 119(9): 1131‐1140.
-
Postoev VA, Grjibovski AM, Nieboer E, Odland Jo (2015) Changes in detection of birth defects and perinatal mortality after introduction of prenatal ultrasound screening in the Kola Peninsula (North-West Russia): combination of two birth registries. BMC Pregnancy Childbirth 15: 308.
-
Ewigman BG, Crane JP, Frigoletto FD, LeFevre ML, Bain RP, et al. (1993) Effect of prenatal ultrasound screening on perinatal outcome. RADIUS Study Group. N Engl J Med 329(12): 821‐827.
-
Bennett MJ, Little G, Dewhurst J, Chamberlain G (1982) Predictive value of ultrasound measurements in early pregnancy: a randomised controlled trial. Br J Obstet Gynaecol 89(5): 338-341.
-
Neilson JP, Munjanja JP, Whitfield CR (1984) Screening for small-for-dates fetuses: a controlled trial. Br Med J 289(6453): 1179-1182.
-
Bakketeig LS, Eik Nes SH, Jacobsen G, Brodtkorb CJ, et al. (1984) Randomised controlled trial of ultrasonographic screening in pregnancy. Lancet 2(8396): 207-211.
-
Berkowitz RL (1993) Should every pregnant woman undergo ultrasonography? N Engl J Med Sep 329(12): 874-875.
-
Golde SH (1994) Prenatal ultrasound screening and perinatal outcome. N Engl J Med 330(8): 570.
-
Abramowicz JS (2013) Benefits and risks of ultrasound in pregnancy. Semin Perinatol 37(5): 295-300.
-
Rao R, Platt LD (2016) Ultrasound screening: Status of markers and efficacy of screening for structural abnormalities. Semin Perinatol 40(1): 67-78.
-
Rayburn WF, Jolley JA, Simpson LL (2015) Advances in ultrasound imaging for congenital malformations during early gestation. Birth Defects Res A Clin Mol Teratol 103(4): 260-268.
-
Whitworth M, Bricker L, Mullan C (2015) Ultrasound for fetal assessment in early pregnancy. Cochrane Database of Systematic Reviews 2015(7): CD007058.
-
Rydberg C, Tunon K (2017) Detection of fetal abnormalities by second-trimester ultrasound screening in a non-selected population. Acta Obstet Gynecol Scand 96(2): 176-182.
-
Kermorvant Duchemin E, Ville Y (2017) Prenatal diagnosis of congenital malformations for the better and for the worse. J Matern Fetal Neonatal Med 30(12): 1402-1406.
-
Abramowicz JS, Kossoff G, Marsal K, Ter Haar G (2003) Safety Statement, 2000 (reconfirmed 2003). International Society of Ultrasound in Obstetrics and Gynecology (ISUOG). Ultrasound Obstet Gynecol 21(1): 100.
-
Torloni MR, Vedmedovska N, Merialdi M, Betran AP, Allen T, et al. (2009) Safety of ultrasonography in pregnancy: WHO systematic review of the literature and meta- analysis. Ultrasound Obstet Gynecol 33(5): 599-608.
-
Fadda GM, Capobianco G, Balata A, Litta P, Ambrosini G, et al. (2009) Routine second trimester ultrasound screening for prenatal detection of fetal malformations in Sassari University Hospital, Italy: 23 years of experience in 42,256 pregnancies. Eur J Obstet Gynecol Reprod Biol 144(2): 110-114.
-
Gagnon A (2009) Evaluation of prenatally diagnosed structural congenital anomalies. J Obstet Gynaecol Can 31(9): 875-881.
-
Debost Legrand A, Laurichesse Delmas H, Francannet C, Perthus I, Gallot D, et al. (2014) False positive morphologic diagnoses at the anomaly scan: marginal or real problem, a population-based cohort study. BMC Pregnancy Childbirth 14: 112.
-
Tegnander E, Eik Nes SH (2006) The examiner’s ultrasound experience has a significant impact on the detection rate of congenital heart defects at the second trimester fetal examination. Ultrasound Obstet Gynecol 28(1): 8-14.
-
Debost-Legrand A, Perthus I, Riviere O, Gallot D, Vendittelli F, et al. (2018) Are there risk factors for false-positive malformation diagnoses on obstetric ultrasound? A nested case-control study. J Gynecol Obstet Hum Reprod 47(3): 107-111.
-
Nicolaides KH (2011) Turning the pyramid of prenatal care. Fetal Diagn Ther 29(3): 183-96.
-
Verrotti C, Caforio E, Gramellini D, Nardelli GB (2007) Ultrasound screening in second and third trimester of pregnancy: an update. Acta Biomed 78(3): 229-232.
-
Sonek JD, Kagan KO, Nicolaides KH (2016) Inverted Pyramid of Care. Clin Lab Med 36(2): 305-317.
-
Salomon LJ, Alfirevic Z, Berghella V, Bilardo C, Johnsen SL, et al. (2011) Practice guidelines for performance of the routine mid-trimester fetal ultrasound scan. Ultrasound Obstet Gynecol 37(1): 116-126.
-
Salomon LJ, Alfirevic Z, Da Silva Costa F, Deter RL, Figueras F, et al. (2019) ISUOG Practice Guidelines: ultrasound assessment of fetal biometry and growth. Ultrasound Obstet Gynecol 53(6): 715-723.
-
Mullins E, Evans D, Viner RM, O Brien P, Morris E (2020) Coronavirus in pregnancy and delivery: rapid review. Ultrasound Obstet Gynecol 55(5): 586-592.
-
Rasmussen SA, Jamieson DJ (2020) Coronavirus Disease 2019 (COVID-19) and Pregnancy: Responding to a Rapidly Evolving Situation. Obstet Gynecol 135(5): 999- 1002.
-
Rasmussen SA, Smulian JC, Lednicky JA, Wen TS, Jamieson DJ (2020) Coronavirus Disease 2019 (COVID-19) and pregnancy: what obstetricians need to know. Am J Obstet Gynecol 222(5):415-426.
-
Poon LC, Yang H, Kapur A, Melamed N, Dao B (2020) Global interim guidance on coronavirus disease 2019 (COVID-19) during pregnancy and puerperium from FIGO and allied partners: Information for healthcare professionals. Int J Gynaecol Obstet 149(3): 273-286.
-
Abramowicz JS, Basseal JM, Brezinka C, Dall Asta A, Deng J, et al. (2020) ISUOG Safety Committee Position Statement on use of personal protective equipment and hazard mitigation in relation to SARS-CoV-2 for practitioners undertaking obstetric and gynecological ultrasound. Ultrasound Obstet Gynecol 55(6): 886-891.
-
Poon LC, Yang H, Dumont S, Lee JCS, Copel JA, et al. (2020) ISUOG Interim Guidance on coronavirus disease 2019 (COVID-19) during pregnancy and puerperium: information for healthcare professionals - an update. Ultrasound Obstet Gynecol 55(6): 848-862.
- Postpartum Maternal Mental Health - A Narrative Review
- Beta HCG in Cervico-Vaginal Secretion as a Predictor of Preterm Delivery
- Successful Management of Mid Trimester Foetal Death with Major Placenta Previa by Expectant Management Followed by Induction of Labour
- To Evaluate the Expression of Egr2 Gene in Term Low Birth Weight Newborns
- Impact of Maternal Obesity on Maternal and Foetal Outcomes: A Prospective Cohort Study from Northern India
- ‘’Benefit of Pulsatile GnRH Therapy in Treatment of Functional Hypothalamic Amenorrhea (FHA) and Congenital Hypogonadotropic Hypogonadism(CHH) in Infertile Patients Over Canonical Gonadotropins with IVF –A Short Communication’’